For subscribers
Health Sciences Authority ensures safety, quality and efficacy of health products
Sign up now: Get ST's newsletters delivered to your inbox
HSA's regulatory agility and flexibility ensured that Singapore was among the earliest to access Covid-19 vaccines, therapies and medical devices.
ST PHOTO: NG SOR LUAN
Follow topic:
SINGAPORE – Singapore has been praised for how quickly and decisively it acted in identifying potential Covid-19 vaccines
As the health authorities raced to secure supplies, Singapore’s Health Sciences Authority (HSA) stepped in to review the clinical trial data to make sure they were safe and effective.
